Clinical Laserthermia Systems AB Stock Swiss Exchange
Equities
CLSR.B
SE0002756130
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- SEK | - |
05-31 | Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue | MT |
05-29 | Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2023 | 8.27M 785K 1.08M | Sales 2024 * | 39M 3.7M 5.1M | Capitalization | 49.52M 4.7M 6.47M |
---|---|---|---|---|---|
Net income 2023 | -79M -7.5M -10.33M | Net income 2024 * | -54M -5.13M -7.06M | EV / Sales 2023 | 20.5 x |
Net cash position 2023 | 14.88M 1.41M 1.94M | Net cash position 2024 * | 29.7M 2.82M 3.88M | EV / Sales 2024 * | 0.51 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 3.26% |
Managers | Title | Age | Since |
---|---|---|---|
Dan J. Mogren
CEO | Chief Executive Officer | - | - |
Founder | 75 | 06-03-08 | |
Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 09-12-31 | |
Hans von Celsing
CHM | Chairman | 74 | 10-12-31 |
Founder | 75 | 06-03-08 |
1st Jan change | Capi. | |
---|---|---|
+1.54% | 856M | |
-28.71% | 225M | |
-32.85% | 77.72M | |
+10.73% | 59.81M |
- Stock Market
- Equities
- CLS B Stock
- CLSR.B Stock